Chesapeake Capital Corp’s Sanofi SNY Stock Holding History

Chesapeake Capital Corp’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,420	Closed	-$543K	–	192
2024 Q3	$543K	Buy	+9,420	New	+$509K	0.49%	91

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Chesapeake Capital Corp's SNY Position: Q4 2024 in Review

Chesapeake Capital Corp sold out of Sanofi (SNY) in Q4 2024, closing a stake of 9,420 shares — an estimated $543K sold.

Chesapeake Capital Corp first reported a position in SNY in Q3 2024 and held it in 1 quarter. The position peaked at $543K in Q3 2024. 730 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

Chesapeake Capital Corp reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
Chesapeake Capital Corp sold 9,420 Sanofi shares in Q4 2024, an estimated $543K.
Chesapeake Capital Corp first reported a position in Sanofi in Q3 2024 and held it in 1 quarter.
Chesapeake Capital Corp's Sanofi position peaked at $543K in Q3 2024.
730 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on Chesapeake Capital Corp's 13F filing for Q4 2024, filed 11 Feb 2025.